Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Synthorx Stock Is Soaring Today


Shares of the clinical-stage biotech Synthorx (NASDAQ: THOR) jumped by an eye-popping 169% right out of the gate Monday morning. What's behind this enormous spike?

Synthorx's stock is on fire today in response to an all-cash buyout agreement with French pharma giant Sanofi (NASDAQ: SNY) for $68 per share. On a fully diluted basis, the total equity value of this buyout works out to a hefty $2.5 billion.  

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
SNY
Share

Comments